Selected Publications

Past fellows have published extensively and been accepted to major academic journals, including: JAMA Dermatology, JAAD, Journal of Drugs in Dermatology, SKIN - The Journal of Cutaneous Medicine, and others. Selected publications include:

  1. Marson, J. W., Maner, B. S., Harding, T. P., Meisenheimer, J., Solomon, J. A., Leavitt, M., Levin, N. J., Dellavalle, R., Brooks, I., & Rigel, D. S. (2021). The Magnitude of COVID-19's Effect on the Timely Management of Melanoma and Non-Melanoma Skin Cancers. Journal of the American Academy of Dermatology84(4), 1100-1103.
  2. Del Rosso, J, Armstrong, AW, Berman, B, Bhatia, N, Cockerell, C, Goldenberg, G, Kirby, JS, Lebwohl, MG, Stein Gold, L, Marson, JW, Rigel, DS. Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report. J Drugs Dermatol. 2021 (Accepted)
  3. Marson, J., Del Rosso, J., Bhatia, N., & Rigel, D. (2021). Considerations in the Management of Actinic Keratoses: The Importance of Adherence and Persistence to Therapy. SKIN The Journal of Cutaneous Medicine5(2), 83–89.
  4. Marson, J., Litchman, G., Svoboda, R., Glazer, A., Farberg, A., Winkelmann, R., & Rigel, D. (2021). Assessment of the 31-Gene Expression Profile Test by Dermatologists: A Cross-Sectional Survey from National Dermatology Conferences. SKIN The Journal of Cutaneous Medicine5(2), 101–107.
  5. Marson, J., Litchman, G., & Rigel, D. (2021). The Differential Impact of COVID-19 on Urban Versus Rural Dermatologic Practice Logistics and Recovery: A Cross-Sectional Investigation of the First Wave. SKIN The Journal of Cutaneous Medicine5(2), 118–124.
  6. Marson JW, Litchman GH, Rigel DS. The Impact of the COVID-19 Pandemic on Physician-Pharmaceutical Office-Based Interactions. J Drugs Dermatol. 2021 Feb 1;20(2):215-223. doi: 10.36849/JDD.2021.5651. PMID: 33538568.
  7. Marson JW, Litchman GH, Rigel DS. The Magnitude of Increased US Melanoma Incidence Attributable to Ground-Level Ultraviolet Radiation Intensity Trends. J Am Acad Dermatol. 2020 Aug 29:S0190-9622(20)32497-X. doi: 10.1016/j.jaad.2020.08.100. Epub ahead of print. PMID: 32871162.
  8. Litchman GH, Marson JW, Rigel DS. The Continuing Impact of COVID-19 on Dermatology Practice: Office Workflow, Economics and Future Implications. J Am Acad Dermatol. 2020 Sep 30:S0190-9622(20)32658-X. doi: 10.1016/j.jaad.2020.08.131. Epub ahead of print. PMID: 33010326; PMCID:
  9. Litchman GH, Teplitz RW, Marson J, Rigel DS. Impact of Electrical Impedance Spectroscopy on Dermatologists' Number-Needed-to-Biopsy Metric and Biopsy Decisions for Pigmented Skin Lesions. J Am Acad Dermatol. 2020 Sep 11:S0190-9622(20)32596-2. doi: 10.1016/j.jaad.2020.09.011. Epub ahead of print. PMID: 32926981.
  10. Litchman, GH, Marson, JW, Svoboda, RN, & Rigel, DS (2020). Integrating Electrical Impedance Spectroscopy into Clinical Decisions for Pigmented Skin Lesions Improves Diagnostic Accuracy: A Multitiered Study. SKIN The Journal of Cutaneous Medicine4(5), 424-430.
  11. Litchman, GH, Marson, JW, Bhatia, N, Berman, B. (2020) Revisiting Handwashing Fundamentals When It Is Absolutely Essential. J Drugs Dermatol. 2020;19(11): 1127-1129 doi:10.36849/JDD.2020.5557
  12. Farberg AS, Glazer AM, Rigel AC, White R, Rigel DS. Dermatologists' Perceptions, Recommendations, and Use of Sunscreen. JAMA Dermatol. 2017;153(1):99-101.
  13. Glazer AM, Farberg AS, Winkelmann RR, Rigel DS. Analysis of Trends in Geographic Distribution and Density of US Dermatologists. JAMA Dermatol. 2017;153(4):322-325.
  14. Glazer AM, Rigel DS. Analysis of Trends in Geographic Distribution of US Dermatology Workforce Density. JAMA Dermatol. 2017;153(5):472-473.
  15. Glazer AM, Holyoak K, Cheever E, Rigel DS. Analysis of US dermatology physician assistant density. J Am Acad Dermatol. 2017;76(6):1200-1202.
  16. Glazer AM, Winkelmann RR, Farberg AS, Rigel DS. Analysis of Trends in US Melanoma Incidence and Mortality. JAMA Dermatol. 2016;
  17. Mirsky RS, Prado G, Svoboda RM, Glazer AM, Rigel DS. Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test. J Drugs Dermatol.
  18. Prado G, Svoboda RM, Teplitz R, Farberg A, Rigel DS. Patient knowledge of FDA-mandated sunscreen labeling
    terminology: a cross-sectional survey. Photodermatol Photoimmunol Photomed.
  19. Svoboda RM, Prado G, Mirsky RS, Rigel DS. Assessment of Clinician Accuracy for Diagnosing Melanoma Based on Electrical Impedance Spectroscopy Score Plus Morphology Versus Lesion Morphology Alone. J Am Acad Dermatol. 2018;
  20. Mirsky R, Prado G, Svoboda RM, Rigel DS.  Oxybenzone and Sunscreens: A Critical Review of the Evidence and a Plan for Discussion with Patients. SKIN - J Cutan Med. 2018;2(5).
  21. Prado G, Nichols AJ, Florez-White M, Kerdel F. Reporting of Quality of Life in Clinical Trials of Biologics for Plaque Psoriasis: A Systematic Review. SKIN - J Cutan Med. 2018;2(5).
  22. Farberg AS, Glazer AM, White R, Rigel DS. Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists' Clinical Management Decisions. J Drugs Dermatol. 2017;16(5):428-431.
  23. Glazer AM, Sofen BD, Rigel DS, Shupack JL. Successful Treatment of Generalized Essential Telangiectasia With 6-Mercaptopurine. J Drugs Dermatol. 2017;16(3):280-282.
  24. Glazer A, Sofen BD, Gallo ES. Nail discoloration after use of hydroquinone. JAAD Case Rep. 2016;2(1):57-8.
  25. Farberg AS, Rigel AC, Rigel DS. Online Survey of US Dermatologists' Sunscreen Opinions: Perceptions, Recommendation Factors, and Self-Usage. J Drugs Dermatol. 2016;15(9):1121-3.